Dr. Price is an experienced biotech executive and entrepreneur with a depth of expertise across clinical asset investment strategy, evaluation, financing and execution. He currently serves as Chief Medical Officer for Cohort Intelligence and prior to this role, he served as the Chief Medical Officer for ProPharma Group’s Pharmacovigilance team. Before joining ProPharma Group, Dr. Price served as CEO of Drug Safety Solutions for over 20 years, until it was successfully acquired by ProPharma Group in 2017.